Verve Therapeutics Inc (NASDAQ: VERV) – Analysts’ Opinion Is Improving
Verve Therapeutics Inc (NASDAQ:VERV) traded at $8.58 at close of the session on Friday, February 14 and made an upward move of 11.28% on its previous day’s price. Looking at the stock we see that its previous close was $7.71 and the beta (5Y monthly)